Akebia Therapeutics Vs. Cara Therapeutics Industry Stock Comparison

Sell

36

AKBA
Akebia Therapeutics

Last Price:

1.37

Seasonality Move:

-2.71%

Sell

11

CARA
Cara Therapeutics

Last Price:

0.30

Seasonality Move:

-11.19%

Sell

36

Akebia Therapeutics (AKBA) is a Sell

Is Akebia Therapeutics a Buy, Sell or Hold?

The current Akebia Therapeutics [AKBA] share price is $1.37. The Score for AKBA is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
AKBA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

Sell

11

Cara Therapeutics (CARA) is a Sell

Is Cara Therapeutics a Buy, Sell or Hold?

The current Cara Therapeutics [CARA] share price is $0.29. The Score for CARA is 11, which is 78% below its historic median score of 50, and infers higher risk than normal.
CARA is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
This Score is currently showing an extreme reading that indicates risk could be especially high.

AKBA Stock Price Chart

What is Akebia Therapeutics's stock price today?

The Akebia Therapeutics share price today is $1.37
The current trend is moderately bearish and AKBA is experiencing slight buying pressure.

CARA Stock Price Chart

What is Cara Therapeutics's stock price today?

The Cara Therapeutics share price today is $0.29
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CARA is experiencing selling pressure, which indicates risk of future bearish movement.

AKBA Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0	Sell
Relative Strength Index (14 RSI):	46.8	Sell
Chaikin Money Flow:	264579	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(1.39 - 1.51)	Sell
Bollinger Bands (100):	(1.07 - 1.43)	Buy

CARA Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.02	Sell
Relative Strength Index (14 RSI):	43.76	Sell
Chaikin Money Flow:	-366348	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(0.29 - 0.35)	Sell
Bollinger Bands (100):	(0.26 - 0.64)	Sell

AKBA Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	1.4	Sell
20-day SMA:	1.44	Sell
50-day SMA:	1.39	Sell
200-day SMA:	1.37	Buy
8-day EMA:	1.39	Sell
20-day EMA:	1.41	Sell
50-day EMA:	1.36	Buy
200-day EMA:	1.3	Buy

CARA Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	0.28	Buy
20-day SMA:	0.31	Sell
50-day SMA:	0.33	Sell
200-day SMA:	0.61	Sell
8-day EMA:	0.29	Buy
20-day EMA:	0.31	Sell
50-day EMA:	0.35	Sell
200-day EMA:	0.92	Sell

Akebia Therapeutics Earnings Growth & AKBA Earnings Dates

Analysts estimate an earnings increase this quarter of $0.04 per share, an increase next quarter of $0.01 per share, an increase this year of $0.14 per share, and an increase next year of $0.01 per share.

Cara Therapeutics Earnings Growth & CARA Earnings Dates

Analysts estimate an earnings increase this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.71 per share, and an increase next year of $0.52 per share.

Akebia Therapeutics Technical Analysis

	Sep 9	Sep 10	Sep 11	Sep 12	Sep 13	Sep 16	Sep 17	Sep 18	Sep 19	Sep 20
	Sep
	09	10	11	12	13	16	17	18	19	20
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Cara Therapeutics Technical Analysis

	Sep 9	Sep 10	Sep 11	Sep 12	Sep 13	Sep 16	Sep 17	Sep 18	Sep 19	Sep 20
	Sep
	09	10	11	12	13	16	17	18	19	20
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):